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Abstract
Background: Avian influenza virus infections cause significant economic losses on poultry farms and pose the
threat of a possible pandemic outbreak. Routine vaccination of poultry against avian influenza is not recommended
in Europe, however it has been ordered in some other countries, and more countries are considering use of the
avian influenza vaccine as a component of their control strategy. Although a variety of such vaccines have been
tested, most research has concentrated on specific antibodies and challenge experiments.
Methods: We monitored the transcriptomic response to a DNA vaccine encoding hemagglutinin from the highly
pathogenic H5N1 avian influenza virus in the spleens of broiler and layer chickens. Moreover, in layer chickens the
response to one and two doses of the vaccine was compared.
Results: All groups of birds immunized with two doses of the vaccine responded at the humoral level by
producing specific anti-hemagglutinin antibodies. A response to the vaccine was also detected in the spleen
transcriptomes. Differential expression of many genes encoding noncoding RNA and proteins functionally
connected to the neuroendocrine-immune system was observed in different immunized groups.
Conclusion: Broiler chickens showed a higher number and wider range of fold-changes in the transcriptional
response than laying hens.
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Background
Avian influenza is a major zoonotic viral disease that
causes significant adverse impacts on poultry production
and the global trade [1]. Previous outbreaks have caused
the loss of hundreds of millions of birds, and total eco-
nomic losses are estimated to be far in excess of US $10
billion [2, 3]. Vaccination of poultry was implemented in
many of the affected countries, especially in those where
H5N1 viruses have become enzootic in poultry and wild
birds [3–6]. Mandatory vaccinations of chickens with
inactivated or recombined H5N1 viruses are considered to
prevent disease and mortality in chickens, reduce human
cases and help to maintain rural livelihoods and food se-
curity [7]. Moreover, vaccination is thought to be the most
effective method to prevent influenza infection [8].
One of the most interesting approaches to influenza
immunization is the use of DNA vaccines. Among the
many advantages of this technique, it is worth highlight-
ing that DNA vaccines are fast to produce and modify;
foreign antigenic protein produced within the host cells
can induce humoral and cellular immune responses and
DNA vaccination leads to immunization with an antigen
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likely to be folded in its native conformation, correctly
glycosylated and having normal post-translational modi-
fications [9, 10]. This last feature is important, because
the glycosylation of HA modulates among other host
immune response [11]. Moreover, they are safe due to
the absence of infective agents and the possibility of
using a single selected antigen, which allows for the dif-
ferentiation of infection in vaccinated animals [10, 12].
Many DNA vaccine candidates for protecting chickens
from avian influenza have been described [10, 13, 14],
and one such vaccine has been licensed for use in the
U.S. [15]. Protective DNA vaccine candidates were also
designed and tested by our team [16–20].
Monitoring the transcriptome of vaccinated animals
can allow for the discovery of vaccine-induced correlates
of protection [21, 22]. To our knowledge, there are only
three articles describing the transcriptomic response of
chickens vaccinated against avian influenza virus. Two
of them showed the response of birds vaccinated with
inactivated low-pathogenic H9N2 virus (A/Chicken/
United Arab Emirates/99), with or without an adjuvant,
and subsequently infected with homologous virus [23,
24]. The third one, by our group, analysed the spleen
transcriptome of broilers (Ross 308) vaccinated with two
doses of protein (protein/protein), two doses of DNA
(DNA/DNA), or the combined prime/boost (DNA/pro-
tein) vaccine against H5 avian influenza [25].
Herein, we compare the previously reported changes
in the transcriptomic profiles of the Ross 308 line vacci-
nated twice with DNA vaccine with the changes in the
transcriptomic profiles of laying chickens of two lines,
White Leghorn maintained under specific pathogen-free
(SPF) conditions and Rosa 1 maintained under standard
bedding conditions. Additionally, the transcriptomic
profiles of Rosa 1 after one dose of DNA vaccine are
presented and discussed.
Methods
Plasmid used for DNA vaccination
The plasmid containing the cDNA encoding full-length
(except the proteolytic cleavage site between the HA1
and HA2 subunits, residues 341–347) hemagglutinin
(HA) from A/swan/Poland/305-135 V08/2006 (H5N1),
clade 2.2, with codons optimized for the domestic
chicken was used for DNA vaccination. Codon bias was
described earlier as K3 [17, 20].
Immunization experiment and spleen collection
Rosa 1 chickens were purchased from a commercial
breeder on the day of hatching and maintained at an
experimental poultry house under standard bedding
conditions. Specific pathogen-free (SPF) White Leghorn
(WL) chickens were purchased from VALO Biomedia
(Germany) and housed in a biosafety level 3
containment facility of the National Veterinary Research
Institute, Pulawy. All groups of birds were primed intra-
muscularly with the DNA vaccine containing 60 μg of
plasmid DNA complexed with Lipofectin on day 7. The
Rosa [1x] group was not given a second dose of the vac-
cine, while the Rosa [2x] and WL [2x] groups were
boosted on day 21. Animals were sacrificed 7 days after
the last immunization; for Rosa [1x] on day 14 of the an-
imal’s life, and in the case of Rosa [2x] and WL [2x], on
day 28 of the animal’s life, and blood samples and
spleens were collected from the experimental groups
and the corresponding control groups, which were
treated with empty plasmid. The spleens were immedi-
ately immersed in RNAlater reagent (Ambion 5:1; RNA-
later:tissue; v:v). In this study we compare results of
immunization of the Rosa 1 and WL breeds with previ-
ously published results of immunization of the Ross 308
breed, where the group was referred to as the DNA/
DNA group [18, 25].
Enzyme-linked immunosorbent assay (ELISA)
Indirect ELISA for detection of anti-HA antibodies in
serum was performed as described previously [17].
Hemagglutination inhibition (HI)
HI tests were performed according to the OIE standard
procedures as described earlier [20]. The hemagglutinat-
ing antigen from strains A/turkey/35/07 (clade 2.2) and
A/crested eagle/Belgium/H5N1/ (clade 1) (kindly pro-
vided by Dr. Thierry van den Berg, Brussels, Belgium)
were used in the WL [2x] group, while the commercially
available hemagglutinating antigen (with 96% protein se-
quence similarity to the vaccine antigen) prepared from
the low pathogenic H5N2 strain A/chicken/Belgium/
150/1999 was used in the Ross [2x] group. HI titres are
shown as the reciprocal of the highest dilution of sera
that completely inhibited hemagglutination.
RNA isolation and microarray experiments
RNA isolation and microarray experiments were per-
formed as described previously [25].
Availability of data and materials
The datasets supporting the conclusions of this article
are available in the GEO repository, accession number
GSE135671 and GSE102972.
Microarray data analysis
Microarray data were analysed as described previously
[25]. Venn diagrams were drawn using UGent webtool
(http://bioinformatics.psb.ugent.be/webtools/Venn/).
Remaining plots were made with MS Excel 2007.
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Statistical analysis
Statistical analysis was performed with R Statistical Soft-
ware [26]. One-factor simple analysis of variance was
done for comparison of mean HI titre between WL and
Ross chickens. One-factor simple analysis of variance
and Tukey-HSD test was done for comparison of mean
ELISA results. Two-way Pearson’s linear correlation test
was done for the correlation analysis.
Results
Humoral response in sera of chickens used for microarray
experiments
The level of anti-H5 HA antibodies in sera collected
from birds used in microarray experiments is shown in
Fig. 1. All groups of boosted chickens (Ross [2x], WL
[2x] and Rosa [2x]) had significantly higher levels of
anti-H5 HA antibodies in their sera than birds from the
Rosa [1x] group, which were given only one dose of the
vaccine (p < 0.0001 for all groups), however differences
in ELISA results between the groups of boosted chicken
were not significant. As expected, the sera of control
birds tested negative in ELISA. The HI titre was assayed
in selected groups in the sera of vaccinated chickens
(Ross [2x] and WL [2x] groups). The HI titre indicated
that the used vaccine stimulated a protective response,
particularly in WL chickens, which had SPF status. HI
titer in the WL [2x] group was significantly higher than
HI titer in the Ross [2x] group [F (1,2) = 169; p = 0.006].
HI titer in Rosa chickens was not determined. The
maximal HI titre in control animal sera was about 8,
which is generally considered background level.
We found a very strong negative correlation (r = −
0.994; p-value = 0.006; N = 4) between HI titer of WL
[2x] and Ross [2x] chickens and the DEGs number in
these groups. The same correlation was observed be-
tween HI titer of WL [2x] and Ross [2x] chickens and
the Fold-Change range. There was no significant correl-
ation between ELISA results and the number of DEGs
nor between ELISA results and Fold-Change range.
Overview of differentially regulated transcript clusters
and genes
The lists of transcript clusters which were up- or down-
regulated (min ± 1.3-fold) with p ≤ 0.05 in chickens from
the respective vaccination variants in comparison with
the appropriate control groups are shown in Tables S1-
S4. A total of 394 (188 up- and 196 downregulated), 55
(29 up- and 26 downregulated), 156 (117 up- and 39
downregulated) and 292 (149 up- and 143 downregu-
lated) transcript clusters showed differential expression
in the Ross [2x], WL [2x], Rosa [2x] and Rosa [1x]
groups, respectively, compared with the unvaccinated
controls (Fig. 2). Most (98.7%) of these transcript clus-
ters were annotated by Affymetrix or successfully identi-
fied using BLAST. In the microarray chips we used, a
single gene may be represented by more than one tran-
script cluster; therefore, the number of identified differ-
entially expressed genes (DEGs) has been reduced to
Fig. 1 Humoral response in sera of immunized chickens used for microarray experiments. ELISA results are show in the chart, while the results of
HI determination using two types of antigens are shown below, if available; the absence of an HI value means that HI was not determined in this
individual. Results are shown for immunized (P) and control (C) individuals. The controls (CNTR1–4) were maintained at the same time as the
respective immunized chickens, but instead of the DNA vaccine, they obtained an identical dose of the empty vector
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375 and 279 in the Ross [2x] and Rosa [1x] groups, re-
spectively, while in the WL [2x] and Rosa [2x] groups
the number of DEGs was equal to the number of differ-
entially expressed transcript clusters. Most DEGs were
unique to a single immunized group; however, 34 DEGs
were common to any two immunized groups (Table S5).
About 56% of these DEGs were regulated in the same
direction in both groups, of which 12 were upregulated
and 7 were downregulated. One of the most strongly up-
regulated genes common to the Ross [2x] group (6.3-
fold) and the Rosa [2x] group (2.3-fold) was GVINP1
(GTPase, very large interferon inducible pseudogene 1).
Functional analysis of DEGs
Significantly enriched GO Terms (p < 0.05) for the Ross
[2x], Rosa [2x] and Rosa [1x] groups are listed in Table 1.
No significantly enriched GO Terms were identified in
the WL [2x] group. All GO Terms were unique; how-
ever, positive regulation of mast cell degranulation (BP:
GO:0043306), significantly enriched in the Ross [2x]
group, is clearly related to the immune response
enriched in the Rosa [2x] group.
Further analysis of individual DEGs allowed us to
distinguish two general subsets: (i) RNA-encoding
DEGs (Table S6) and (ii) DEGs connected to
neuroendocrine-immune system (NE_Imm DEGs,
Table S7). Representation of these categories was var-
ied in different immunized groups (Fig. 3). The RNA-
encoding DEGs were most frequently represented in
the WL [2x] group (22% of all DEGs) and in the Rosa
[1x] group (20% of all DEGs), while in the Rosa [2x]
and the Ross [2x] groups, they represented only 10
and 4% of all DEGs, respectively. The NE_Imm DEGs
were most frequently represented in the WL [2x]
group (50% of all DEGs) and in the Rosa [2x] group
(43% of all DEGs).
RNA-encoding DEGs
Most of the RNA-encoding DEGs (13, 10, 10 and 43 in
the Ross [2x], WL [2x], Rosa [2x] and Rosa [1x] groups,
respectively) belonged to the miRNA and snoRNA clas-
ses. SNORA56 was differentially expressed in two
groups, WL [2x] and Rosa [1x] (Table S5); however, it
was downregulated in the former and upregulated in lat-
ter. Differences in the expression of this gene seem to be
quite high (fold-change: − 1.65 vs. 3.05). Other snoRNAs
that were differentially expressed in more than one
group included: (i) SNORA5 and SNORD35, which were
upregulated in the WL [2x] and Rosa [1x] groups; (ii)
SNORA26, which was upregulated in the Rosa [2x] and
Rosa [1x] groups and (iii) SNORA74 and MIR1757,
which were differentially regulated in the Ross [2x] and
Rosa [1x] groups. Interestingly, the former was down-
and upregulated, whereas the latter was up- and
downregulated in the Ross [2x] and Rosa [1x] groups, re-
spectively. Interestingly, the genes from this category
were highly overrepresented among the 15 most upregu-
lated genes in the Rosa (1x) group (Fig. 4, Table 2). Two
and six of the miRNAs encoding DEGs from the WL
[2x] and Rosa [1x] groups, respectively, have been re-
ported in connection with the neuroendocrine-immune
system (Table S7).
DEGs related to the neuroendocrine-immune system
This category included 86, 23, 60 and 74 DEGs in the
Ross [2x], WL [2x], Rosa [2x] and Rosa [1x] groups, re-
spectively (Table S7). Many of them were present only
in one vaccinated group. Others, like the genes encoding
the major histocompatibility complex (MHC), form a
very large set, with members present in different groups,
and most of them were upregulated. The remaining
genes from this category that were present in more than
one group included genes encoding: (i) Nestin (NES),
Fig. 2 Venn diagrams of differentially expressed transcript clusters in
the immunized groups
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which was downregulated in the Ross [2x], WL [2x] and
Rosa [1x] groups, (ii) Solute Carrier Family 8 Mem-
ber A3 (SLC8A3), which was downregulated in the
WL [2x] and Rosa [1x] groups, (iii) Potassium
Calcium-Activated Channel Subfamily M Alpha 1
(KCNMA1), which was upregulated in the Rosa [2x]
and Rosa [1x]) groups, (iv) Argininosuccinate syn-
thase 1 (ASS1), encoding protein engaged in negative
regulation of leukocyte cell-cell adhesion, which was
down- and upregulated in the Rosa [2x] and Rosa
[1x] groups, respectively, (v) heat shock protein
HSPB1, which was downregulated in the Ross [2x]
and Rosa [1x] groups, (vi) Granzyme M (GZMM)
and Colony stimulating factor 3 receptor (CSF3R),
both upregulated in the Ross [2x] and Rosa [2x]
groups, (vii) Calpain 2 (CAPN2) which was down-
and upregulated in the Ross [2x] and Rosa [2x]
groups, respectively and (viii) EF-hand calcium-
binding domain-containing protein 4B (EFCAB4B),
which was up- and downregulated in the Ross [2x]
and Rosa [2x] groups, respectively.
The DEGs from this category were highly overrepre-
sented among the 15 most upregulated genes in the Ross
[2x]) group and also (but to a much lesser extent) in the
WL [2x] group (Table 2, Fig. 4). Moreover, the NE_Imm
DEGs were the only DEGs with a log2(ratio) higher than
2 (Fig. 4).
Discussion
The effects of immunization were first verified at the
humoral level. All groups of birds immunized with two
doses of the vaccine responded by producing specific
anti-HA antibodies. Then, we focused on changes in the
spleen transcriptome, evaluated in each immunized
group in relation to their respective controls.
Immunization of broiler chickens (the Ross [2x] group)
resulted in the largest number of DEGs, while vaccin-
ation of White Leghorn SPF chickens (the WL [2x]
group) revealed the smallest number of DEGs (Fig. 2,
Fig. 4). Interestingly, despite a low level of anti-H5 HA
antibodies in sera, the Rosa [1x] group, immunized with
one dose, showed more DEGs and higher fold-changes
than the Rosa [2x] group, vaccinated twice (Fig. 1, Fig. 2,
Fig. 4). All chickens vaccinated twice showed similar
level of anti-H5 HA antibodies in sera (Fig. 1), however
White Leghorn SPF chickens displayed significantly
higher HI titre than Ross chickens (and HI titre of Rosa
chickens was not determined). HI titre was negatively
correlated with the number and Fold-Change range of
DEGs. We believe that strong and quick secondary re-
sponse initiated by memory cells can cause lower
changes in gene expression in spleen at day 7 post
vaccination.
Moreover, the microarray chips used in this work
(Affymetrics Chicken Gene 1.1 ST Array) were built,
Table 1 Top GO terms that were significantly enhanced in the vaccinated groups. BP, Biological Process, MF, Molecular Function
GO Category ID Description Gene count p-value
Ross [2x]
BP: GO:0043306 positive regulation of mast cell degranulation 2 2.8E-02
BP: GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity 4 1.5E−2
MF: GO:1990782 protein tyrosine kinase binding 2 2.6E-2
BP: GO:0030154 cell differentiation 6 2.8E-2
BP: GO:0003151 outflow tract morphogenesis 3 3.5E-2
BP: GO:0007223 Wnt signalling pathway, calcium modulating pathway 2 3.5E-2
BP: GO:0034446 substrate adhesion-dependent cell spreading 3 4.0E-2
BP: GO:0090090 negative regulation of canonical Wnt signalling pathway 4 4.40E-3
Rosa [2x]
MF: GO:0004060 arylamine N-acetyltransferase activity 2 3.0E-2
BP: GO:0006955 immune response 4 4.9E-2
Rosa [1x]
BP: GO:0007154 cell communication 4 6.7E-4
BP: GO:0032781 positive regulation of ATPase activity 3 6.3E-3
BP: GO:0006629 lipid metabolic process 4 1.4E-2
BP: GO:0001666 response to hypoxia 4 2.1E-2
BP: GO:0051592 response to calcium ion 3 2.9E-2
BP: GO:0086005 ventricular cardiac muscle cell action potential 2 4.4E-2
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according to the Affymetrix DataSheet, on the galGal3
genome founded on the Red Jungle fowl (Gallus gallus),
one of the main ancestors of domestic chickens (Gallus
domesticus). Some studies imply that broiler chickens
are more closely related to Red Jungle fowl than layers
[27], which could be the reason for the higher number
of DEGs detected in broilers (the Ross [2x] group) than
in the layers represented by all remaining groups (Fig. 2).
On the other hand, broilers may also show more DEGs
because of breed selection. For example, the transcrip-
tional profile of the breast muscle in heat-stressed layers
was similar to that of broiler chickens kept at the control
temperature, while heat stress amplified changes in
broilers [28].
The chicken genome was the first completed genome
of a breeding animal [29]; now, the fourth version
(Gallus_gallus-5.0), corrected among others by
annotation of 2768 noncoding genes and many CHIR
loci, has been released [30]. The number of chicken
mRNAs seems to be lower than in humans [31]; how-
ever, the chicken transcriptome seems to show a similar
level of complexity [32]. That explains the relatively high
representation of RNA-encoding DEGs in our results.
Moreover, mammalian long non-coding RNAs
(lncRNAs) were reported to play critical roles in the im-
mune response to influenza A virus infection [33], and
some lncRNAs were identified as being related to the
immune response to influenza A virus in ducks [34];
however, the roles of many non-coding RNAs remain to
be discovered. Interestingly, the proportion of RNA-
encoding DEGs of all DEGs is far less in broilers (the
Ross [2x] group) than in all remaining groups (Fig. 3). In
fact, the number of RNA-encoding DEGs in both groups
of Rosa 1 chickens (Rosa [2x] and Rosa [1x]) is higher
Fig. 3 Enriched groups of DEGs among all DEGs identified in the study. NEI_RNA genes, DEGs encoding RNA related to the neuroendocrine-
immune system; nonNEI_RNA genes, DEGs encoding RNA without known relation to the neuroendocrine-immune system; NEI_DEGs, DEGs
encoding proteins related to the neuroendocrine-immune system; OtherDEGs DEGs encoding proteins without known relation to the
neuroendocrine-immune system
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than that in broilers (the Ross [2x] group), despite a sig-
nificantly smaller overall number of DEGs (Fig. 2, Fig. 4,
Table S6). The RNA-encoding DEGs reported in this
study belong mainly to the miRNA and snoRNA classes
(Table S6). Deep sequencing of the transcriptomes of
skeletal muscles from broiler and layer chickens showed
that they share a few millions common miRNAs; how-
ever, tens of thousands miRNAs were still specific to ei-
ther broiler or layer skeletal muscle [35]. Interestingly,
during that study the sequence tag annotations demon-
strated that known chicken miRNAs and metazoan
miRNA homologs accounted for about 50% of all se-
quence reads in the broiler and layer libraries, whereas
snoRNAs were only slightly represented, although se-
quencing was in that case performed by fractionating
total RNA using polyacrylamide gel electrophoresis to
enrich for molecules in the range of 16–30 nt [35]. Dif-
ferential expression of many miRNAs between the lungs
of broilers infected with H5N3 and those of non-
infected animals was also reported previously [36]. Some
snoRNAs were differentially expressed between the vari-
ous immunized groups (Table S5). Despite the variety in
chicken breeds and differences in maintenance condi-
tions, some of these differences may be caused by the
recognition of snoRNA derivatives by the Transcript
Clusters optimized to detect snoRNA molecules [37, 38].
Moreover, Transcript Clusters optimized for detection
of certain mRNA can detect also regulatory RNA made
from pseudogenes [39]. This fact, together with different
time points, can explain differences between expression
level of some DEGs (e.g. ASS1, EFCAB4B and UTS2R)
in various studied group.
Our study reports differential regulation of many
ImmDEGs in spleens of chickens vaccinated with the ex-
perimental DNA vaccine (Table S7). Among them one
can find numerous DEGs encoding cytokines (CCLi9,
IL5 and IL17D) and their receptors (CCR7, CCR8,
CCR8L, CX3CR1, CXCR4, IL1R2, IL5RA, IL12RB2,
Fig. 4 Scatterplots highlighting regulation of enriched groups of DEGs among all DEGs identified in the study. NEI_RNA genes, DEGs encoding
RNA related to the neuroendocrine-immune system; nonNEI_RNA genes, DEGs encoding RNA without known relation to the neuroendocrine-
immune system; NEI_DEGs, DEGs encoding proteins related to the neuroendocrine-immune system; OtherDEGs DEGs encoding proteins without
known relation to the neuroendocrine-immune system
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IL17REL and IL28RA). To our knowledge, at least 10 of
the ImmDEGs identified in this study (TLR2–1, IRG1,
MX1, OASL, IFIT5, CXCR4, DDX60, NFKBIZ, IFNA
and IL12RB2) were reported as differentially expressed
during experimental infection of chickens or chicken
cells with H5 influenza viruses. TLR2–1 was overex-
pressed in the lungs of chickens infected with the highly
pathogenic AIV H5N1 strain A/Chicken/Jiangsu/k0402/
2010 [40] and was found by us as a DEG in the WL [2x]
group. IRG1 was downregulated in CEF cells infected
with H5N2 virus [41] and was identified by us as a DEG
in the Rosa [1x] group. The regulation of these two
genes observed in this study seems to have proinflam-
matory consequences (Table S7).
MX1, OASL and IFIT5 genes encode proteins with
known functions in influenza defense [41]. MX1 was the
most overexpressed gene in the Rosa 1 [2x] group
(Table 2), and its overexpression was also reported in
CEF cells and chickens infected with H5N1 or H5N2 vi-
ruses [40, 42] and in the lungs of chickens infected with
Table 2 TOP 15 up- and downregulated DEGs in the vaccinated groups. RNA-encoding DEGs and DEGs connected to the
neuroendocrine-immune system are bolded and underlined, respectively
Ross[2x] WL[2x] Rosa[2x] Rosa[1x]
Up-regulated
Gene Symbol FC Gene Symbol FC. Gene Symbol FC Gene Symbol FC
GAL7 14,7 SNORD35 2,03 MX1 2,50 SNORA56 3,05
GAL1 9,4 GRM8 2,02 GVIN1 2,30 MHC region 2,88
GAL2 9,1 USP6NL 2,00 ISG12–2 2,23 U11 2,68
GAL6 8,3 MGST2 1,84 MHC 2,01 MIR1743 2,51
LECT2 6,8 MHC class I 1,80 ncRNA 2,01 – 2,32
GVIN1 6,3 gga-mir-147 1,76 ncRNA 2,01 MIR1596 1,96
TCRDV 4,9 OAT 1,69 ncRNA 2,01 C9ORF58 1,96
6TBGa-2 3,4 SLC2A9 1,68 ncRNA 2,01 MIR7B 1,93
SERPINB10 3,1 C2H6ORF105 1,53 LAMA1 1,93 SNORA66 1,89
LOC100858620 2,9 BORCS5 1,50 ZP1 1,83 SNORA23 1,87
RHCE 2,8 NONGGAT007307 1,50 TSPO2 1,82 MIR1680 1,87
S100A9 2,6 NADB-LER2 1,49 LAG3 1,77 SNORD90 1,87
ACKR2 2,5 STAM2 1,47 ARHGEF39 1,73 RPL23 1,84
SNORD24 2,4 TIFA 1,42 CCR8 1,72 SNORD14 1,82
TIMMDC1 2,3 CCLi9 gene 1,42 LYGL 1,72 ND4L 1,81
Down-regulated
DDX60 -2,9 IGLV −5,12 – −3,77 PRED.: LOC107050276 −4,28
DDX60 −2,9 GDPD2 −1,85 – −2,07 CIAO1 −2,98
snoRNA GGN47 −2,9 LRRC4C −1,77 GIMAP7L5 −2,00 SLC8A3 −2,25
NTMT1 −2,8 SNORA56 −1,65 IL28RA −1,97 PRED.: MICA −2,21
EYA1 −2,7 IFNA −1,58 MIR1637 −1,82 PRED.: CYP2J2L2 − 1,97
RRBP1 −2,4 MIR1636 −1,55 TDRD5 −1,64 CHIR-B5 −1,79
GPR158 −2,2 AICDA −1,53 GRTP1 −1,60 LOC431321 −1,78
LRRC3B −2,2 ACTA2 −1,52 MRPL13 −1,59 PRED.: LOC100859143 −1,77
ALDH1A3 −2,1 LOC100858370 −1,46 CACNB4 −1,58 PTPRZ1 −1,75
STXBP5L −2,1 MIR1648 −1,43 ABI3BP −1,56 COCH −1,70
IFIT5 −2,0 ACTG2 −1,41 VH57–1 −1,51 Mt_tRNA −1,69
OASL −1,9 SLC8A3 −1,41 LOC107050168 −1,51 PRED.: TMEM98 −1,67
MDK −1,8 LOC776492 −1,40 LACC1 −1,50 LECT1 −1,65
MI0005509 −1,8 OLFML3 −1,39 LOC107055505 −1,45 PRED.: OR14A16L45 −1,64
SNORD18 −1,7 TMC6 −1,37 KCNK12 −1,45 SLC38A3 −1,63
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H5N1 virus from 24 h post infection [43]. The OASL
gene was downregulated in the Ross [2x] group; how-
ever, it was upregulated in CEF cells infected with H5
viruses at 4 h post infection [42]. Regulation of the ex-
pression of this gene in the lungs of chickens infected
with highly pathogenic H5N1 virus depended on the
time point [40]. IFIT5 was overexpressed in CEF cells in-
fected with H5 viruses at 12 h post infection [40] and
downregulated in the Ross [2x] group. Differences in ex-
pression of the OASL and IFIT5 genes may result from
differences in the experimental setup. Regulation of
CXCR4, DDX60 and NFKBIZ varied at different time
points after infection of chicken lungs [40]. IFNA was
up- and IL12RB2 was downregulated in lungs of chick-
ens infected with H5N1 virus [43], whereas they were
upregulated in the spleens of chickens vaccinated in this
study (the WL [2x] and Ross [2x] group, respectively).
In summary, broiler chickens (Ross 308) showed a
higher number and wider range of fold-changes in the
transcriptional response than laying hens (White Leg-
horn or Rosa 1). Interestingly, White Leghorn SPF
chickens had a lower number and lower range of fold-
changes than the Rosa 1 breed. Moreover, the number
and range of gene expression changes was higher in the
Rosa 1 group that received one dose than in the Rosa 1
group that was boosted. In all groups many RNA-
encoding DEGs and DEGs connected to the
neuroendocrine-immune system were identified. Their
representation was higher in laying chicken breeds than
in broilers. Some genes (detected in this study) function-
ally connected to the immune response were also re-
ported as differentially expressed during experimental
influenza infection of chickens or chicken cells.
Conclusion
Our results indicate that different chicken breeds might
respond differentially to the vaccination. The vaccination
stimulates response in spleen transcriptome which could
be used in future for selection of the markers of the vac-
cine effectiveness.
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